Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 26, No 16 (June 1), 2008: pp. 2707-2716
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2007.15.6521

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Publisher's Note
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Zhu, X.-D.
Right arrow Articles by Sun, H.-C.
PubMed
Right arrow Articles by Zhu, X.-D.
Right arrow Articles by Sun, H.-C.

High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma

Xiao-Dong Zhu, Ju-Bo Zhang, Peng-Yuan Zhuang, Hong-Guang Zhu, Wei Zhang, Yu-Quan Xiong, Wei-Zhong Wu, Lu Wang, Zhao-You Tang, Hui-Chuan Sun

From the Liver Cancer Institute and Zhongshan Hospital, and Department of Pathology and Pathology Research Center, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China

Corresponding author: Hui-Chuan Sun, MD, PhD, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China; e-mail: sun.huichuan{at}zs-hospital.sh.cn

Purpose: To investigate prognostic values of the intratumoral and peritumoral expression of macrophage colony-stimulating factors (M-CSF) in hepatocellular carcinoma (HCC) patients after curative resection.

Patients and Methods: Expression of M-CSF and density of macrophages (M{Phi}) were assessed by immunohistochemistry in tissue microarrays containing paired tumor and peritumoral liver tissue from 105 patients who had undergone hepatectomy for histologically proven HCC. Prognostic value of these and other clinicopathologic factors was evaluated.

Results: Neither intratumoral M-CSF nor M{Phi} density was associated with overall survival (OS) or disease-free survival (DFS). High peritumoral M-CSF and M{Phi} density, which correlated with large tumor size, presence of intrahepatic metastasis, and high TNM stage, were independent prognostic factors for both OS (P = .001 and P < .001, respectively) and DFS (P = .001 and P = .003, respectively) and affected incidence of early recurrence. In a small HCC subset, peritumoral M-CSF was also correlated with both OS and DFS (P = .038 and P = .001, respectively). The combination of peritumoral M-CSF and M{Phi} had a better power to predict the patients' death and disease recurrence (P < .001 for both).

Conclusion: High peritumoral M-CSF and M{Phi} were associated with HCC progression, disease recurrence, and poor survival after hepatectomy, highlighting the importance of peritumoral tissue in the recurrence and metastasis of HCC. M-CSF and M{Phi} may be targets of postoperative adjuvant therapy.

Supported by Grants No. 30672037 and 30300400 from the National Natural Science Foundation of China and the Foundation of China National "211" Project for Higher Education.

Both X.-D.Z. and J.-B.Z. contributed equally to this work.

Terms in blue are defined in the glossary, found at the end of this article and online at www.jco.org.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.






About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online